Global Diabetic Macular Edema Market: Segmented by Therapy Type (Anti-VEGF, Corticosteroids, Other Off-label Drugs), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2019-2028.
- Published Date: 2022-12-26
- Report ID: 138035
- Pages: 200
-
Format:
Report Overview
The global diabetic macular edema market size stood at around USD 3.7 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Diabetic Macular Edema market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of diabetes, growing adoption of recently approved intravitreal implants in certain geographic regions and growing awareness.
Market Drivers
The rising population suffering from diabetes, causing diabetic macular edema in the patients will help in driving the growth of the diabetic macular edema treatment market. The new and innovative research & development for the treatment of diabetic macular edema will likely to accelerate the growth of the diabetic macular edema treatment market in the forecast period of 2019-2028. On the other hand, advancement in ophthalmic surgery techniques and R&D investment by pharmaceutical companies will further boost various opportunities that will lead to the growth of the diabetic macular edema treatment market in the forecast period.
High medical costs for the patients and the frequent visits to the physicians will likely to hamper the growth of the diabetic macular edema treatment market in the forecast period.
1. Global Diabetic Macular Edema Market Overview........................
A. Market Size
2. Market Growth Drivers.
A. Rising Population Suffering from Diabetes
B. New and Innovative Research & Development for the Treatment of Diabetic Macular Edema
3. Five Forces Analysis........................................................................................................................
A. Bargaining Power of Buyers
B. Bargaining Power of Suppliers
C. Threat of New Entrants
D. Threat of Substitutes
E. Threat of Rivalry
F. Market Condition
4. Diabetic Macular Edema Market Segmentation........................
A. Treatment
I. Laser Photocoagulation Therapy
II. Pharmacological Therapy
III. Bevacizumab
IV. Ranibizumab
V. Triamcinolone
B. Distribution Channel
I. Hospitals
II. Ophthalmic Clinics
III. Research Institutes
IV. Contract Research Organizations
C. Geography
V. North America Market Analysis
VI. Europe Market Analysis
VII. Asia-Pacific Market Analysis
VIII. Middle-East and Africa Market Analysis
IX. South America Market Analysis
5. Diabetic Macular Edema Major Products Market Share
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. Allergan PLC Company overview, Product & Services, Strategies & Financials
B. Clearside Biomedical, Inc. Company overview, Product & Services, Strategies & Financials
C. Novartis AG Company Profile, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Recent Developments
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
